Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Longitudinal Detection of DNMT3A R882H Transcripts in Patients with Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 3959.

https://doi.org/10.1182/blood.V130.Suppl_1.3959.3959

Published: 2017

Journal Articles

MRD-Directed Post-Remissional Therapy Dramatically Improves Outcome of Adult Patients with High Risk AML by Implementing Allogeneic Transplant Option

Blood (2010) 116 (21): 2702.

https://doi.org/10.1182/blood.V116.21.2702.2702

Published: 2010

Journal Articles

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

Blood (2010) 116 (13): 2295–2303.

https://doi.org/10.1182/blood-2009-12-258178

Published: 2010

Includes: Supplemental data

Journal Articles

Decisional Algorithm to Incorporate Hematopoietic Stem Cell Transplantation in the Management of Adult Patients with Acute Myeloid Leukaemia.

Francesco Buccisano, M.D., Luca Maurillo, Maria Ilaria Del Principe, Giovanni Del Poeta, Paola Panetta, Emanuele Ammatuna, Licia Ottaviani, Chiara Sarlo, Micol Quaresima, Gottardo De Angelis, Manuela Rizzo, Selenia Campagna, Francesco Lo Coco, William Arcese, Sergio Amadori, Adriano Venditti

Blood (2008) 112 (11): 1519.

https://doi.org/10.1182/blood.V112.11.1519.1519

Published: 2008

Journal Articles

Flow-Cytometric Minimal Residual Disease Determination Is a Surrogate Prognosticator in Adult AML Patients Lacking Specific Molecular Signatures.

Francesco Buccisano, MD, Luca Maurillo, MD, Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Daniela Fraboni, PhD, Emanuele Ammatuna, MD, Maria Irno Consalvo, PhD, Paola Panetta, PhD, Licia Ottaviani, MD, Sabrina Faccia, MD, Manuela Rizzo, MD, Massimiliano Postorino, MD, Maria Cantonetti, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2007) 110 (11): 3498.

https://doi.org/10.1182/blood.V110.11.3498.3498

Published: 2007

Journal Articles

Detection of Minimal Residual Disease by Flow-Cytometry Otimizes Risk Stratification When Combined with Cytogenetics in AML.

Francesco Buccisano, MD, Luca Maurillo, MD, Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Paola Panetta, PhD, Daniela Fraboni, PhD, Maria Irno Consalvo, PhD, Daniela Renzi, MD, Selenia Campagna, MD, Chiara Sarlo, MD, Luca Franceschini, MD, Laura Giannì, MD, Emanuele Ammatuna, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2007) 110 (11): 4242.

https://doi.org/10.1182/blood.V110.11.4242.4242

Published: 2007

Journal Articles

Optimal Post-Remission Therapy for Flow-Cytometry Minimal Residual Disease Positive Patients with Acute Myeloid Leukemia.

Francesco Buccisano, MD, Luca Maurillo, MD, Valter Gattei, MD, Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Fraboni Fraboni, Phd, Paola Panetta, Phd, Maria Irno Consalvo, Phd, Selenia Campagna, MD, Laura Giannì, MD, Licia Ottaviani, MD, Massimiliano Postorino, MD, Paolo De Fabritiis, MD, William Arcese, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2006) 108 (11): 610.

https://doi.org/10.1182/blood.V108.11.610.610

Published: 2006

Journal Articles

Statistical Validation of a Threshold To Discriminate Flow-Cytometry Minimal Residual Disease (MRD) Levels with Prognostic Significance in Acute Myeloid Leukemia (AML).

Francesco Buccisano, MD, Luca Maurillo, MD, Valter Gattei, MD, Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Paola Panetta, Phd, Daniela Fraboni, Phd, Maria Irno Consalvo, Phd, Licia Ottaviani, MD, Daniela Renzi, MD, Sabrina Faccia, MD, Chiara Sarlo, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2006) 108 (11): 2299.

https://doi.org/10.1182/blood.V108.11.2299.2299

Published: 2006

Journal Articles

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia

Blood (2006) 108 (3): 853–861.

https://doi.org/10.1182/blood-2005-12-4986

Published: 2006

Journal Articles

Spontaneous Apoptosis and Proliferation Predict Disease Progression within ZAP-70 Negative B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Pasquale Niscola, MD, Luca Maurillo, MD, Adriano Venditti, MD, Francesco Buccisano, MD, Maria Irno Consalvo, PhD, Carla Mazzone, MD, Paola Panetta, PhD, Massimo Degan, PhD, Irene Pasqua, PhD, Antonio Bruno, PhD, Valter Gattei, MD, Francesco Lo Coco, MD, Sergio Amadori, MD

Blood (2005) 106 (11): 1197.

https://doi.org/10.1182/blood.V106.11.1197.1197

Published: 2005

Journal Articles

ZAP-70 Protein Retains Its Prognostic Significance within Interphase Cytogenetic Groups in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Maria Ilaria Del Principe, M.D., Giovanni Del Poeta, M.D., Maria Christina Cox, M.D., Paola Panetta, Ph.D., Luca Maurillo, M.D., Adriano Venditti, M.D., Maria Irno Consalvo, Ph.D, Valter Gattei, M.D., Francesco Lo Coco, M.D., Sergio Amadori, M.D.

Blood (2004) 104 (11): 2806.

https://doi.org/10.1182/blood.V104.11.2806.2806

Published: 2004

Journal Articles

Ph-Abnormal Clones Emerged during Imatinib Therapy: Clinical Report and Clonal Analyses on 23 Patients from GIMEMA Working Party (GWP) in CML Registry.

Elisabetta Abruzzese, MD, Alessandro Gozzetti, MD, Alfonso Zaccaria, MD, Nicoletta Testoni, MD, Sara Galimberti, MD, Malgorzata M. Trawinska, MD, Tommaso Caravita, MD, Paola Panetta, BS, Marco Mancini, MD, Dario Ferrero, MD, Michela Salvio, MD, Franca Radaelli, MD, Federica Sora’, MD, Gianantonio Rosti, Sergio Amadori, MD, Michele Baccarani, MD

Blood (2004) 104 (11): 2936.

https://doi.org/10.1182/blood.V104.11.2936.2936

Published: 2004

Journal Articles

Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML): Presented in part at the 42nd annual meeting of the American Society of Hematology, San Francisco, CA, December 1-5, 2000. 46

Giovanni Del Poeta, Adriano Venditti, Maria Ilaria Del Principe, Luca Maurillo, Francesco Buccisano, Anna Tamburini, Maria Christina Cox, Annibale Franchi, Antonio Bruno, Carla Mazzone, Paola Panetta, Giovanna Suppo, Mario Masi, Sergio Amadori

Blood (2003) 101 (6): 2125–2131.

https://doi.org/10.1182/blood-2002-06-1714

Published: 2003

NARROW

Longitudinal Detection of DNMT3A R882H Transcripts in Patients with Acute Myeloid Leukemia

MRD-Directed Post-Remissional Therapy Dramatically Improves Outcome of Adult Patients with High Risk AML by Implementing Allogeneic Transplant Option

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

Decisional Algorithm to Incorporate Hematopoietic Stem Cell Transplantation in the Management of Adult Patients with Acute Myeloid Leukaemia.

Flow-Cytometric Minimal Residual Disease Determination Is a Surrogate Prognosticator in Adult AML Patients Lacking Specific Molecular Signatures.

Detection of Minimal Residual Disease by Flow-Cytometry Otimizes Risk Stratification When Combined with Cytogenetics in AML.

Optimal Post-Remission Therapy for Flow-Cytometry Minimal Residual Disease Positive Patients with Acute Myeloid Leukemia.

Statistical Validation of a Threshold To Discriminate Flow-Cytometry Minimal Residual Disease (MRD) Levels with Prognostic Significance in Acute Myeloid Leukemia (AML).

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia

Spontaneous Apoptosis and Proliferation Predict Disease Progression within ZAP-70 Negative B-Cell Chronic Lymphocytic Leukemia (B-CLL).

ZAP-70 Protein Retains Its Prognostic Significance within Interphase Cytogenetic Groups in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Ph-Abnormal Clones Emerged during Imatinib Therapy: Clinical Report and Clonal Analyses on 23 Patients from GIMEMA Working Party (GWP) in CML Registry.

Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML): Presented in part at the 42nd annual meeting of the American Society of Hematology, San Francisco, CA, December 1-5, 2000. 46

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only